Prolieve
Hospitals & Physicians Clinics · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10240 Old Columbia Rd Ste G, Columbia, M...Phone Number
(410) 290-5734Website
www.prolieve.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Prolieve
Prolieve specializes in providing non-surgical treatment options for Benign Prostatic Hyperplasia (BPH), focusing on delivering immediate relief to patients. The company emphasizes safety and effectiveness in its approach, catering to individuals experiencing BPH symptoms and complications. Prolieve aims to support patients through educational resources, clinical data, and insurance coverage information. Their services are designed for men seeking effective solutions for BPH-related issues.Explore more
Popular SearchesProlieveMedifocus IncProlieve Thermodilatation SystemUs - Prolieve®SIC Code 80,809NAICS Code 62,621Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prolieve your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Prolieve launches new products
Click to see if Prolieve had a recent Job posting/layoffs
Earning: See what the market has to say on Prolieve recently announced quarterly report
Check out if Prolieve is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Prolieve
Funding: Get notified immidiatlly once Prolieve has new funding data
Prolieve, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Prolieve has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Prolieve
Compare insights from companies similar to Prolieve, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Prolieve
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Prolieve is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Prolieve is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Prolieve.
Prolieve Tech Stack
A closer look at the technologies used by Prolieve
Prolieve News & Media
Medifocus, Inc. Announces Recent Publication Highlighting Its Focal Therapy for Prostate and Breast Cancer Treatment Initiatives
COLUMBIA, Md. and TORONTO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, today announced that a company overview of the Medifocus’ novel Prolieve® Transurethral Thermodilatation™ (TUTD™) for the treatment of BPH and the potential of extending such technology platfMedifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ Device
Prolieve® is a Novel Combinational Treatment for Benign Prostatic Hyperplasia (BPH) Prolieve® is a Novel Combinational Treatment for Benign Prostatic Hyperplasia (BPH)Medifocus, Inc. Expands Its Reach into the Israeli Market with Amos Gazit Ltd. for Its Prolieve(R) Thermodilatation for BPH Therapy and Announces Significant Debt Conversion into Shares
COLUMBIA, MD / ACCESSWIRE / January 9, 2018 / Medifocus, Inc. (OTCQB: MDFZF; TSX-V: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer, is pleased to announce that it has entered into an exclusive distribution agreement (the "Agreement") with Amos Gazit, Ltd. ("Amos Gazit") to market and distribute the Company's proven Prolieve® Thermodi
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prolieve
Sign Up For FreeTo access detailed company insights
Prolieve specializes in providing non-surgical treatment options for Benign Prostatic Hyperplasia (BPH), focusing on delivering immediate relief to patients. The company emphasizes safety and effectiveness in its approach, catering to individuals experiencing BPH symptoms and complications. Prolieve aims to support patients through educational reso... Read More
